Veeva Systems Inc. (VEEV)
Automate Your Wheel Strategy on VEEV
With Tiblio's Option Bot, you can configure your own wheel strategy including VEEV - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol VEEV
- Rev/Share 17.5443
- Book/Share 38.1637
- PB 7.3743
- Debt/Equity 0.0124
- CurrentRatio 4.6049
- ROIC 0.0939
- MktCap 45989039160.0
- FreeCF/Share 7.396
- PFCF 38.2066
- PE 58.6711
- Debt/Assets 0.0099
- DivYield 0
- ROE 0.1374
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 4
Recent Analyst Ratings
Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
---|---|---|---|---|---|---|---|
Reiterated | VEEV | Needham | -- | Buy | $270 | $300 | May 29, 2025 |
Downgrade | VEEV | Goldman | Buy | Sell | $261 | $200 | Jan. 23, 2025 |
Initiation | VEEV | Stephens | -- | Overweight | -- | $280 | Dec. 20, 2024 |
Initiation | VEEV | Mizuho | -- | Outperform | -- | $275 | Dec. 4, 2024 |
Initiation | VEEV | Exane BNP Paribas | -- | Outperform | -- | $286 | Oct. 8, 2024 |
Reiterated | VEEV | Citigroup | -- | Buy | $256 | $273 | Aug. 27, 2024 |
News
VEEV Stock May Gain on the Launch of China Campaign Manager for Pharma
Published: June 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva Systems launches China Campaign Manager to boost pharma engagement with localized, compliant CRM-driven solutions.
Read More
Veeva Systems Inc. (VEEV) Hits Fresh High: Is There Still Room to Run?
Published: June 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva (VEEV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
Why Veeva Systems (VEEV) is a Top Momentum Stock for the Long-Term
Published: June 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Best Momentum Stocks to Buy for June 11th
Published: June 11, 2025 by: Zacks Investment Research
Sentiment: Positive
SSRM, VEEV and BAESY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 11, 2025.
Read More
Is Veeva (VEEV) a Buy as Wall Street Analysts Look Optimistic?
Published: June 11, 2025 by: Zacks Investment Research
Sentiment: Neutral
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read More
Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
Published: June 05, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to Veeva (VEEV). This makes it worthwhile to examine what the stock has in store.
Read More
Veeva Systems: AI And Vault CRM Are Key Long-Term Tailwinds
Published: June 05, 2025 by: Seeking Alpha
Sentiment: Positive
I rate Veeva Systems as a hold, as the current price is close to my new intrinsic value of $322 per share, limiting the margin of safety. Veeva's Q1 FY2026 results were outstanding, driven by Vault CRM migration, AI integration, Crossix performance, and strong SMB sector recovery. Veeva's innovation pace, deep industry specialization, and expanding AI features reinforce its moat versus Salesforce and IQVIA, supporting long-term growth.
Read More
Veeva Systems Inc. (VEEV) Presents at Annual William Blair Growth Stock Conference Transcript
Published: June 04, 2025 by: Seeking Alpha
Sentiment: Neutral
Veeva Systems Inc. (NYSE:VEEV ) Annual William Blair Growth Stock Conference June 4, 2025 2:20 PM ET Company Participants Brian Van Wagener - Chief Financial Officer Conference Call Participants Dylan Tyler Becker - William Blair & Company L.L.C., Research Division Dylan Tyler Becker Thank you, everybody.
Read More
Veeva Systems Inc. (VEEV) Baird Global Consumer, Technology & Services Conference (Transcript)
Published: June 03, 2025 by: Seeking Alpha
Sentiment: Neutral
Veeva Systems Inc. (NYSE:VEEV ) Baird Global Consumer, Technology & Services Conference Call June 3, 2025 10:50 AM ET Company Participants Paul Shawah - Executive Vice President of Strategy & Campaign Manager Conference Call Participants Joseph D. Vruwink - Robert W.
Read More
Understanding Veeva (VEEV) Reliance on International Revenue
Published: June 03, 2025 by: Zacks Investment Research
Sentiment: Neutral
Examine Veeva's (VEEV) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Read More
Veeva to Present at Upcoming Investor Conferences
Published: May 30, 2025 by: PRNewsWire
Sentiment: Neutral
PLEASANTON, Calif. , May 30, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conferences: Baird 2025 Global Consumer, Technology & Services Conference, New York, NY.
Read More
Veeva Systems Analysts Boost Their Forecasts After Better-Than-Expected Earnings
Published: May 29, 2025 by: Benzinga
Sentiment: Positive
Veeva Systems Inc. VEEV posted better-than-expected earnings for the first quarter and raised the outlook on Wednesday.
Read More
VEEV Stock Up as Q1 Earnings & Revenues Beat Estimates, Margin Rise
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva Systems' fiscal first-quarter results reflect impressive performance by the Subscription services segment, along with the expansion of gross and operating margins.
Read More
Veeva Stock Spikes 22% After Earnings Beat. What Analysts Are Saying.
Published: May 29, 2025 by: Barrons
Sentiment: Positive
The cloud-solutions company beats first-quarter earnings forecasts and issues better-than-expected fiscal-year guidance.
Read More
Reasons to Retain Veeva Systems Stock in Your Portfolio for Now
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive
VEEV's robust product portfolio and a slew of strategic deals raise optimism about the stock.
Read More
2 AI-Driven Tech Stocks to Buy Before they Surge in June
Published: May 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Diving into some best-in-class, beaten-down tech stocks to buy before everyone else on Wall Street starts searching for deals again.
Read More
Brokers Suggest Investing in Veeva (VEEV): Read This Before Placing a Bet
Published: May 26, 2025 by: Zacks Investment Research
Sentiment: Negative
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read More
Veeva (VEEV) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Published: May 23, 2025 by: Zacks Investment Research
Sentiment: Neutral
Evaluate the expected performance of Veeva (VEEV) for the quarter ended April 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Read More
Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It
Published: May 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
Veeva Systems (VEEV) Increases Despite Market Slip: Here's What You Need to Know
Published: May 20, 2025 by: Zacks Investment Research
Sentiment: Negative
Veeva Systems (VEEV) closed the most recent trading day at $240.78, moving +0.48% from the previous trading session.
Read More
Saudi Arabia Pharmaceutical Quality Management Software Market Forecast and Opportunities, 2030F Featuring MasterControl, AmpleLogic, Pilgrim, Sparta Systems, Dassault, Veeva Systems, and Ideagen
Published: May 16, 2025 by: GlobeNewsWire
Sentiment: Neutral
The Saudi Arabia Pharmaceutical Quality Management Software Market is projected to grow from USD 14.48 Million in 2024 to USD 26.92 Million by 2030, with a CAGR of 10.85%. This growth is driven by the expansion of the pharmaceutical industry and the increasing adoption of digital solutions like AI and cloud computing to enhance quality control. Compliance with strict regulatory standards and the push towards automation are also key factors in the market's development. Vision 2030 initiatives further boost the demand for innovative PQMS solutions to support the burgeoning pharmaceutical sector. The Saudi Arabia Pharmaceutical Quality Management Software Market is …
Read More
Life Sciences Leaders Advance Unified Engagement at Veeva Commercial Summit
Published: May 06, 2025 by: PRNewsWire
Sentiment: Neutral
AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly and Company, and more share strategies for more connected customer experiences across sales, marketing, and medical PLEASANTON, Calif. , May 6, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced its keynote speakers for the 2025 Veeva Commercial Summit, May 13-14 in Boston.
Read More
Veeva: Our 2025 Software Pick Just Keeps Winning
Published: May 06, 2025 by: Seeking Alpha
Sentiment: Positive
I believe Veeva's robust product roadmap, including the introduction of Veeva AI, should deepen adoption and drive productivity across its Development and Commercial Cloud segments. Despite a projected revenue growth slowdown in FY26, Veeva's management remains confident in achieving its $6B revenue target by 2030. VEEV's strong financial discipline is evident, with non-GAAP operating margins expected to expand to 43% in FY26 despite a projected revenue slowdown.
Read More
Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
3 Medical Info Systems Stocks to Ride the AI Wave in Trump Tariff Era
Published: April 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks Medical Info Systems industry stocks like VEEV, HIMS and BFLY are expected to gain from the Stargate Project and provide relief amid tariff tension.
Read More
Wall Street Bulls Look Optimistic About Veeva (VEEV): Should You Buy?
Published: April 18, 2025 by: Zacks Investment Research
Sentiment: Neutral
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read More
Flatiron Health Joins Veeva's Product Partner Program to Accelerate Oncology Clinical Research
Published: April 16, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)--Flatiron Health, a healthtech company transforming clinical research through solutions that integrate research into everyday care, today announced they will partner with Veeva Systems, a global leader in cloud software for the life sciences industry. As part of the partnership, Flatiron Health will join the Veeva Product Partner Program. This collaboration builds on the integration of Flatiron Clinical Pipe™ and Veeva EDC (Electronic Data Capture), enhancing value and.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: April 11, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Read More
Veeva (VEEV) Moves 3.7% Higher: Will This Strength Last?
Published: April 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva (VEEV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Read More
Why Is Veeva (VEEV) Down 6.2% Since Last Earnings Report?
Published: April 04, 2025 by: Zacks Investment Research
Sentiment: Negative
Veeva (VEEV) reported earnings 30 days ago. What's next for the stock?
Read More
About Veeva Systems Inc. (VEEV)
- IPO Date 2013-10-16
- Website https://www.veeva.com
- Industry Medical - Healthcare Information Services
- CEO Mr. Peter P. Gassner
- Employees 7291